Elanco Animal Health (ELAN) Long-Term Investments (2017 - 2018)
Elanco Animal Health's (ELAN) quarterly Long-Term Investments came in at $15.3 million in Q4 2018, up 24.39% year-over-year from $12.3 million in Q4 2017, and up 2.68% quarter-over-quarter from $14.9 million in Q3 2018.
Powered by 
Analysis
Elanco Animal Health (ELAN) Long-Term Investments (2017 - 2018) Analysis & Trends
Elanco Animal Health has disclosed Long-Term Investments across 2 years of filings, most recently posting $15.3 million for Q4 2018.
- In Q4 2018, Long-Term Investments rose 24.39% year-over-year to $15.3 million; the TTM figure through Dec 2018 stood at $15.3 million (up 24.39% YoY), while the FY2018 annual figure was $15.3 million, up 24.39% from the prior year.
- Long-Term Investments came in at $15.3 million for Q4 2018 at Elanco Animal Health, up from $14.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $15.3 million in Q4 2018 to a low of $12.3 million in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 8.76 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | 30.53 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 15.30 Mn |
| Sep 30, 2018 | 14.90 Mn |
| Dec 31, 2017 | 12.30 Mn |